AR103484A1 - TRIPTOLID AND ITS DERIVATIVES IN THE TREATMENT OF PRECANCER TUMORS AND SKIN PATHOLOGIES - Google Patents

TRIPTOLID AND ITS DERIVATIVES IN THE TREATMENT OF PRECANCER TUMORS AND SKIN PATHOLOGIES

Info

Publication number
AR103484A1
AR103484A1 ARP160100173A ARP160100173A AR103484A1 AR 103484 A1 AR103484 A1 AR 103484A1 AR P160100173 A ARP160100173 A AR P160100173A AR P160100173 A ARP160100173 A AR P160100173A AR 103484 A1 AR103484 A1 AR 103484A1
Authority
AR
Argentina
Prior art keywords
derivatives
treatment
triptolid
precancer
tumors
Prior art date
Application number
ARP160100173A
Other languages
Spanish (es)
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of AR103484A1 publication Critical patent/AR103484A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compuesto seleccionado de triptólido, sus derivados, y sales farmacéuticamente aceptables de triptólido y sus derivados, o una composición que comprende dicho un compuesto para su uso en el tratamiento tópico y/o prevención de un tumor o patología precancerosa de la piel.Compound selected from triptolide, its derivatives, and pharmaceutically acceptable salts of triptolide and its derivatives, or a composition comprising said a compound for use in the topical treatment and / or prevention of a tumor or precancerous skin pathology.

ARP160100173A 2015-01-22 2016-01-22 TRIPTOLID AND ITS DERIVATIVES IN THE TREATMENT OF PRECANCER TUMORS AND SKIN PATHOLOGIES AR103484A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1550512A FR3031900A1 (en) 2015-01-22 2015-01-22 TRIPTOLID AND DERIVATIVES THEREOF IN THE TREATMENT OF TUMORS AND CUTANEOUS PRE-CANCER DISEASES

Publications (1)

Publication Number Publication Date
AR103484A1 true AR103484A1 (en) 2017-05-10

Family

ID=53200086

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160100173A AR103484A1 (en) 2015-01-22 2016-01-22 TRIPTOLID AND ITS DERIVATIVES IN THE TREATMENT OF PRECANCER TUMORS AND SKIN PATHOLOGIES

Country Status (4)

Country Link
AR (1) AR103484A1 (en)
FR (1) FR3031900A1 (en)
TW (1) TW201632182A (en)
WO (1) WO2016116587A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111440185B (en) * 2020-03-31 2021-05-14 中国农业科学院蜜蜂研究所 Hapten and application thereof in detection of tripdiolide and triptolide
CN111494319A (en) * 2020-06-15 2020-08-07 沈阳药科大学 Triptolide compound composition and preparation method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2728466A1 (en) * 1994-12-26 1996-06-28 Debiopharm Sa Use of Tripterygium Wilfordii Hook F plant extracts and its components
US6629835B2 (en) * 2000-08-01 2003-10-07 Metaproteomics, Llc Combinations of diterpene triepoxide lactones and ditepene lactones or triterpenes for synergistic inhibition of cyclooxygenase-2
US8501214B2 (en) * 2007-11-26 2013-08-06 Modetex Biomedical Materials & Technology Industrial Corp. Hydrophilic foam and pharmaceutical dosage form employing the same
FR2952072B1 (en) * 2009-11-05 2013-09-27 Pf Medicament PROCESS FOR PRODUCING TRIPTOLIDE

Also Published As

Publication number Publication date
TW201632182A (en) 2016-09-16
WO2016116587A1 (en) 2016-07-28
FR3031900A1 (en) 2016-07-29

Similar Documents

Publication Publication Date Title
CO2019007839A2 (en) Compositions and methods for inhibiting the action of arginase
CO2018008761A2 (en) Maitansinoid derivatives, conjugates of the same methods of use
CL2018003207A1 (en) Procedures for treating skin cancer through the administration of a pd-1 inhibitor.
DOP2020000102A (en) HELPFUL COMPOUNDS TO INHIBIT CDK7
CO2017004525A2 (en) Ror-gamma inhibitory dihydropyrrolopyridines
CL2016001231A1 (en) Autotaxin Inhibitor Compounds
CL2016003422A1 (en) Lysine specific demethylase-1 inhibitors
CL2018003444A1 (en) Adenosine derivatives for use in the treatment of cancer.
CL2012003415A1 (en) Compounds derived from 2-oxo-piperidine and 1,1-dioxide-thiazine, mdm2 inhibitors; pharmaceutical composition that includes them; and its use for the treatment of cancer.
CL2014001793A1 (en) Compounds derived from substituted 1,3,5-triazines and their salts, as inhibitors of mutant idh2; pharmaceutical composition that includes them; and its use for the treatment of cancer.
CL2016003423A1 (en) Lysine specific demethylase-1 inhibitors
CL2014002873A1 (en) Compounds derived from pyrimidin-amine or triazin-amine, adn-pk inhibitors; pharmaceutical composition; and its use for the treatment of cancer.
UY36153A (en) 3-QUINASA DELTA PHOSFOINOSYTI INHIBITORS FOR USE IN THE TREATMENT OF AN IMMUNOAMPOLLOSUS CUTANEOUS DISEASE MEDIATED BY AUTOANTIBODIES?
CL2016001756A1 (en) Pharmaceutical preparation comprising 0.001-0.003 pv of 6-4-pyrazol-1-ylbenzylpyridin-3-ylsulfonylaminomethylpyridin-2-ylaminoacetate isopropyl or a salt of the same use for the treatment or prevention of glaucoma or ocular hypertension.
BR112017011316A2 (en) heterocyclic derivatives and use of these
CL2016003074A1 (en) Compounds derived from 2-oxy-2-phenyl-n-5-pyrrolidin-3-ylamino-1,3,4-thiadiazol-2-ylacetamide, pharmaceutical composition gls1 inhibitors and their use to treat cancer.
AR101414A1 (en) PIRROLIDINONE DERIVATIVES AS METAP-2 INHIBITORS
CL2016002151A1 (en) Pyridazine derivatives for use in the prevention or treatment of an ataxic disorder
AR112144A1 (en) COMPOUNDS FOR THE TREATMENT OF SARCOMA
NI201500175A (en) NEW COMPOUNDS FOR THE TREATMENT OF CANCER
DOP2016000297A (en) PHARMACEUTICAL COMPOSITIONS USEFUL TO TREAT INFECTIOUS DISEASES
IT201600081379A1 (en) Pharmaceutical composition for use in the treatment of prostatic diseases.
CU20150176A7 (en) DERIVATIVES OF SUPPLY OF SUBSTITUTED TRIAZOLPIRIDINES
AR100289A1 (en) FORMS OF A PI3K INHIBITOR
AR103484A1 (en) TRIPTOLID AND ITS DERIVATIVES IN THE TREATMENT OF PRECANCER TUMORS AND SKIN PATHOLOGIES

Legal Events

Date Code Title Description
FB Suspension of granting procedure